InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019)
InfuSystem Holdings (INFU) posted Total Non-Current Liabilities of $52.1 million for Q2 2019, up 9.7% on a QoQ basis from $47.5 million in Q1 2019, and up 53.89% year-over-year from $33.9 million in Q2 2018.
InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019) Analysis & Trends
InfuSystem Holdings' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $52.1 million for Q2 2019.
- Quarterly Total Non-Current Liabilities rose 53.89% year-over-year to $52.1 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $52.1 million (up 53.89% YoY) and the FY2018 annual result came in at $43.6 million, up 15.04% from the prior year.
- Total Non-Current Liabilities was $52.1 million for Q2 2019 at InfuSystem Holdings, up from $47.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $52.1 million in Q2 2019 and bottomed at $2.1 million in Q1 2017.
- A 5-year average of $34.1 million and a median of $33.8 million in 2018 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2016 — Total Non-Current Liabilities declined 1.9% — and 2018, when it soared 1471.9%.
- InfuSystem Holdings' Total Non-Current Liabilities stood at $29.8 million in 2015, then decreased by 1.9% to $29.2 million in 2016, then rose by 29.82% to $37.9 million in 2017, then climbed by 15.04% to $43.6 million in 2018, then rose by 19.43% to $52.1 million in 2019.
- Business Quant data shows INFU's Total Non-Current Liabilities at $52.1 million in Q2 2019, $47.5 million in Q1 2019, and $43.6 million in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 52.11 Mn |
| Mar 31, 2019 | 47.50 Mn |
| Dec 31, 2018 | 43.63 Mn |
| Sep 30, 2018 | 43.39 Mn |
| Jun 30, 2018 | 33.86 Mn |
| Mar 31, 2018 | 33.73 Mn |
| Dec 31, 2017 | 37.93 Mn |
| Sep 30, 2017 | 26.64 Mn |
| Jun 30, 2017 | 29.02 Mn |
| Mar 31, 2017 | 2.15 Mn |
| Dec 31, 2016 | 29.22 Mn |
| Dec 31, 2015 | 29.78 Mn |
| Sep 30, 2013 | 34.77 Mn |
| Jun 30, 2013 | 34.94 Mn |
| Mar 31, 2013 | 35.70 Mn |
| Dec 31, 2012 | 37.51 Mn |
| Mar 31, 2012 | 35.62 Mn |
| Dec 31, 2011 | 35.68 Mn |
| Sep 30, 2011 | 38.36 Mn |
| Jun 30, 2011 | 36.01 Mn |